Eledon Pharmaceuticals, Inc.

Healthcare

NASDAQ:ELDN · NASDAQ Capital Market

Market Cap $221.81M Beta 0.97 P/E (TTM) -5.5

$3.92 +2.84%

+$0.11 today

52W Low $1.35High $4.60

Vol 2.64M · Avg 1.37M

EPS (TTM) -$0.70Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+44.12%

Period High

$4.36

Period Low

$1.39

Latest

$3.92

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Achieve Life Sciences, Inc.

NASDAQ:ACHV

$502.84M

Allogene Therapeutics, Inc.

NASDAQ:ALLO

$488.93M

Puma Biotechnology, Inc.

NASDAQ:PBYI

$376.91M

Vanda Pharmaceuticals Inc.

NASDAQ:VNDA

$349.09M

Atea Pharmaceuticals, Inc.

NASDAQ:AVIR

$346.92M

Abeona Therapeutics Inc.

NASDAQ:ABEO

$325.16M

Entrada Therapeutics, Inc.

NASDAQ:TRDA

$267.86M

Editas Medicine, Inc.

NASDAQ:EDIT

$256.99M

Voyager Therapeutics, Inc.

NASDAQ:VYGR

$223.86M

Humacyte, Inc.

NASDAQ:HUMA

$156.32M

What is the latest ELDN filing?

The latest filing shown is SC 13G/A dated May 15, 2026.

How many recent filings does ELDN have?

Intrinsic Alpha currently shows 20 recent filings for ELDN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.